Individuals Discontinuing Slimming Medications Gain Back Pounds at a Quadrupled Rate Than Those on Conventional Diets

New research suggests that individuals who stop using popular GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop conventional diet and exercise plans.

Research printed in a prominent medical journal demonstrates that while overweight individuals can lose a large proportion of their total mass while using the jabs, the mass comes back at an average rate of nearly a kilo each month after stopping.

"People purchasing such medications should be informed of the potential of quick rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery means a reversion to starting mass in about 18 months.

Analyzing Treatments

The analysis, which examined dozens of studies involving thousands of patients, contrasted the results of the injectable medications with older methods.

The team note that people who shed pounds through dieting generally see a slower creep back—approximately 100 grams monthly—once they finish.

Explaining the Fast Regain

Nutrition scientists propose the way of the injections explains the accelerated regain.

The injections copy a natural hormone called glucagon-like peptide-1, which controls hunger.

"Artificially providing the hormone levels far above than the body's typical production could lead to the system to produce less of its endogenous hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement means appetite is unsuppressed, making excessive eating far more likely."

An Ongoing Condition?

Health authorities recommend the jabs for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Professionals say that, due to the likelihood of relapse, the treatment should be considered ongoing.

This view is reinforced by drug manufacturers, who note that the results "emphasize the long-term character of excess weight," similar to managing diseases like hypertension.

User Experiences

Individuals who have stopped the medication report a sudden resurgence of appetite.

"It was like something that goes on and you're instantly ravenous," said one woman.

This challenge is compounded if users have not developed permanent lifestyle or habit modifications during treatment.

Growing Interest

Survey data suggest that millions of adults in the UK have used these injections in the past year, with desire being substantial.

• Use is higher among women compared to males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a magic cure and maintained weight loss relies on ongoing lifestyle support.